| （単位：千ドル） | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 23,083 | 27,610 | 33,298 | 8,425 | 13,114 | 15,325 | 11,721 | 6,471 | 7,467 | 17,976 | 23,818 | 31,737 | 32,130 | 36,571 |
| 営業費用 | 64,747 | 74,646 | 86,750 | 15,430 | 20,079 | 21,481 | 16,247 | 13,602 | 13,438 | 23,444 | 30,179 | 38,352 | 38,072 | 42,433 |
| 営業利益 | -10,409 | -9,899 | -12,104 | -15,430 | -20,079 | -21,481 | -16,247 | -13,602 | -13,438 | -23,444 | -30,179 | -38,352 | -38,072 | -42,433 |
| 純利益 | -10,915 | -9,675 | -12,088 | -15,788 | -20,027 | -21,436 | -16,235 | -13,900 | -13,294 | -23,465 | -30,527 | -38,776 | -41,066 | -47,047 |
| 一株あたり利益 | - | - | - | - | - | - | - | - | - | - | -0.52 | -0.65 | -0.74 | -0.76 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | - | - | - | -0.52 | -0.65 | -0.74 | -0.76 |
| EBITDA | - | - | - | - | - | - | - | - |